3M posted quarterly adjusted earnings of $2.48 per share, lower than the $2.65 a share that analysts polled by FactSet had expected. Sales decreased to $8.70 billion from the year-ago quarter’s $8.95 billion and reflected a negative impact from foreign-exchange rates of 4 percentage points. The FactSet consensus estimate was $8.57 billion.
The company slashed its outlook to -2.5% to -0.5% sales growth for the full year, from its prior expectation of positive growth of 1% to 4%. It also lowered its adjusted EPS forecast to $10.30 to $10.80 compared with a prior forecast for $10.75 to $11.25. "Looking ahead, we updated our adjusted full-year expectations largely due to the strength of the U.S. dollar and uncertain macroeconomic environment," CEO Mike Roman mentioned in a press release. "We remain focused on innovating for customers, driving operational improvements and advancing our environmental stewardship - while positioning 3M for the future through our plan to spin off our Health Care business and resolve Combat Arms litigation in a manner that is efficient and equitable."